汉族双相障碍遗传风险新位点的全基因组关联研究与荟萃分析
该研究对汉族双相障碍(BD)开展全基因组关联研究(GWAS)并独立复制,发现TMEM108附近新风险位点,跨种族分析显示汉族与欧洲人群BD遗传风险存在共享,荟萃分析另识别VRK2和RHEBL1附近2个新位点。
要点
- 汉族BD发现GWAS样本1822例患者与4650名对照,复制样本958例患者与2050名对照。
- TMEM108附近rs9863544达全基因组显著性(P=2.49×10-8;OR=0.650;95%CI 0.559-0.756)。
- 跨种族遗传相关ρge=0.652(SE=0.106;P=7.30×10-10),支持汉族与欧洲人群共享BD遗传风险。
核心结论
- 该GWAS研究识别了多个与BD遗传风险相关的位点和基因,为其遗传结构和生物学基础提供了见解。
研究设计与样本
- 研究为GWAS加独立复制,在汉族人群中识别BD风险位点,患者按DSM-IV诊断且无精神分裂症、精神发育迟滞或物质依赖史,对照无任何精神疾病个人或家族史。
- 发现阶段1822例患者和4650名对照通过质控进入GWAS分析,复制阶段纳入958例患者和2050名对照。
主要发现
- 汉族发现GWAS样本1822例患者平均(SD)年龄35.43(14.12)岁、838例(46%)男性,4650名对照平均(SD)年龄27.48(5.97)岁、2465名(53%)男性。
- 复制样本958例患者平均(SD)年龄37.82(15.54)岁、412例(43%)男性,2050名对照平均(SD)年龄27.50(6.00)岁、1189名(58%)男性。
- 在TMEM108基因附近发现汉族BD新风险位点rs9863544(P=2.49×10-8;OR=0.650;95%CI 0.559-0.756),该基因与齿状回树突棘发育和谷氨酸能传递相关。
- 跨种族遗传相关估计ρge=0.652(SE=0.106;P=7.30×10-10),多基因风险评分分析最大责任量表Nagelkerke伪R2=1.27%(P=1.30×10-19),显示汉族与欧洲人群存在共享BD遗传风险。
- 荟萃分析识别VRK2附近rs41335055(P=4.98×10-9;OR=0.849;95%CI 0.804-0.897)和RHEBL1附近rs7969091(P=3.12×10-8;OR=0.932;95%CI 0.909-0.956)2个新GWAS风险位点。
关键数值与推荐
- 单核苷酸变异P<5.00×10-8被认为具有全基因组统计学显著性关联。
临床怎么用
- 研究结果提示TMEM108、VRK2和RHEBL1等位点可能参与BD遗传风险,为理解其生物学基础提供线索。
- 跨种族遗传共享证据支持汉族与欧洲人群BD遗传风险存在部分重叠。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The genetic basis of bipolar disorder (BD) in Han Chinese individuals is not fully understood. OBJECTIVE: To explore the genetic basis of BD in the Han Chinese population. DESIGN, SETTING, AND PARTICIPANTS: A genome-wide association study (GWAS), followed by independent replication, was conducted to identify BD risk loci in Han Chinese individuals. Individuals with BD were diagnosed based on DSM-IV criteria and had no history of schizophrenia, mental retardation, or substance dependence; individuals without any personal or family history of mental illnesses, including BD, were included as control participants. In total, discovery samples from 1822 patients and 4650 control participants passed quality control for the GWAS analysis. Replication analyses of samples from 958 patients and 2050 control participants were conducted. Summary statistics from the European Psychiatric Genomics Consortium 2 (PGC2) BD GWAS (20 352 cases and 31 358 controls) were used for the trans-ancestry genetic correlation analysis, polygenetic risk score analysis, and meta-analysis to compare BD genetic risk between Han Chinese and European individuals. The study was performed in February 2020. MAIN OUTCOMES AND MEASURES: Single-nucleotide variations with P < 5.00 × 10-8 were considered to show genome-wide significance of statistical association. RESULTS: The Han Chinese discovery GWAS sample included 1822 cases (mean [SD] age, 35.43 [14.12] years; 838 [46%] male) and 4650 controls (mean [SD] age, 27.48 [5.97] years; 2465 [53%] male), and the replication sample included 958 cases (mean [SD] age, 37.82 [15.54] years; 412 [43%] male) and 2050 controls (mean [SD] age, 27.50 [6.00] years; 1189 [58%] male). A novel BD risk locus in Han Chinese individuals was found near the gene encoding transmembrane protein 108 (TMEM108, rs9863544; P = 2.49 × 10-8; odds ratio [OR], 0.650; 95% CI, 0.559-0.756), which is required for dendritic spine development and glutamatergic transmission in the dentate gyrus. Trans-ancestry genetic correlation estimation (ρge = 0.652, SE = 0.106; P = 7.30 × 10-10) and polygenetic risk score analyses (maximum liability-scaled Nagelkerke pseudo R2 = 1.27%; P = 1.30 × 10-19) showed evidence of shared BD genetic risk between Han Chinese and European populations, and meta-analysis identified 2 new GWAS risk loci near VRK2 (rs41335055; P = 4.98 × 10-9; OR, 0.849; 95% CI, 0.804-0.897) and RHEBL1 (rs7969091; P = 3.12 × 10-8; OR, 0.932; 95% CI, 0.909-0.956). CONCLUSIONS AND RELEVANCE: This GWAS study identified several loci and genes involved in the heritable risk of BD, providing insights into its genetic architecture and biological basis.
引用
- Li HJ, Zhang C, Hui L, et al. Novel Risk Loci Associated With Genetic Risk for Bipolar Disorder Among Han Chinese Individuals: A Genome-Wide Association Study and Meta-analysis. JAMA Psychiatry. 2021. PMID: 33263727. doi:10.1001/jamapsychiatry.2020.3738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。